AR054361A1 - Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas - Google Patents

Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas

Info

Publication number
AR054361A1
AR054361A1 ARP060101983A ARP060101983A AR054361A1 AR 054361 A1 AR054361 A1 AR 054361A1 AR P060101983 A ARP060101983 A AR P060101983A AR P060101983 A ARP060101983 A AR P060101983A AR 054361 A1 AR054361 A1 AR 054361A1
Authority
AR
Argentina
Prior art keywords
treatment
acid
propenous
metoxidifenil
adamantil
Prior art date
Application number
ARP060101983A
Other languages
English (en)
Spanish (es)
Inventor
Claudio Pisano
Loredana Vesci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR054361A1 publication Critical patent/AR054361A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
ARP060101983A 2005-05-20 2006-05-17 Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas AR054361A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.

Publications (1)

Publication Number Publication Date
AR054361A1 true AR054361A1 (es) 2007-06-20

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101983A AR054361A1 (es) 2005-05-20 2006-05-17 Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas

Country Status (13)

Country Link
US (1) US7635719B2 (enExample)
EP (1) EP1890671B1 (enExample)
JP (1) JP5072833B2 (enExample)
KR (1) KR101307910B1 (enExample)
CN (1) CN101180028B (enExample)
AR (1) AR054361A1 (enExample)
AU (1) AU2006248981B2 (enExample)
BR (1) BRPI0611289A2 (enExample)
CA (1) CA2606567A1 (enExample)
IT (1) ITRM20050248A1 (enExample)
MX (1) MX2007014222A (enExample)
TW (1) TWI365753B (enExample)
WO (1) WO2006122883A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it) 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
MXPA04008684A (es) * 2002-03-12 2004-12-06 Galderma Res & Dev Uso de adapaleno para tratamiento de trastornos dermatologicos.

Also Published As

Publication number Publication date
EP1890671A1 (en) 2008-02-27
KR101307910B1 (ko) 2013-09-16
TWI365753B (en) 2012-06-11
EP1890671B1 (en) 2014-03-05
WO2006122883A1 (en) 2006-11-23
CN101180028A (zh) 2008-05-14
ITRM20050248A1 (it) 2006-11-21
TW200716192A (en) 2007-05-01
AU2006248981A1 (en) 2006-11-23
MX2007014222A (es) 2008-02-07
WO2006122883A9 (en) 2012-10-04
BRPI0611289A2 (pt) 2010-08-31
CA2606567A1 (en) 2006-11-23
US20080153916A1 (en) 2008-06-26
AU2006248981B2 (en) 2011-06-02
KR20080016573A (ko) 2008-02-21
US7635719B2 (en) 2009-12-22
JP2008540603A (ja) 2008-11-20
CN101180028B (zh) 2010-12-08
JP5072833B2 (ja) 2012-11-14
HK1117737A1 (en) 2009-01-23

Similar Documents

Publication Publication Date Title
AR084691A1 (es) Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
AR052057A1 (es) Composiciones orales que contienen extractos de rosmarinus y metodos ralacionados
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
UY27921A1 (es) Acidos tienil-hidroxamicos sustituidos y su uso para tratar enfermedades asociadas con la actividad enzimática de la histona desacetilasa
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
AR069563A1 (es) Composicion para el cuidado personal que comprende una mezcla eutetica con un agente anticaspa a base de ketoconasol
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
AR084197A1 (es) Composicion para uso topico para el tratamiento de trastornos de la piel
MX2013004394A (es) Composicion farmaceutica topica de mupirocina.
PE20090640A1 (es) Composicion pulverizable que contiene extracto de hojas de parra rojas
ECSP077843A (es) Tratamiento o prevención del prurito
MX2020010747A (es) Formulaciones topicas que comprenden estroncio y metilsulfonilmetano (msm) y metodos de tratamiento.
AR054361A1 (es) Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas
DK2004235T3 (da) Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse
AR094035A1 (es) Estimulantes del colageno y su uso en el tratamiento de la piel
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
CU20130004A7 (es) Agentes terapéuticos 976
AR077451A1 (es) Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
AR056018A1 (es) Una composicion para usar en la piel

Legal Events

Date Code Title Description
FA Abandonment or withdrawal